» Articles » PMID: 28731820

Uncommon Neoplasms of the Biliary Tract: Radiological Findings

Overview
Journal Br J Radiol
Specialty Radiology
Date 2017 Jul 22
PMID 28731820
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To report our cancer centre experience in the biliary tumours incidence other than cholangiocellular-carcinoma, emphasizing the radiological features.

Methods: 197 patients with biliary disease undergoing Gd-EOB-DTPA-enhanced MRI were reviewed. Four radiologists evaluated retrospectively size, structure, anatomical site and signal intensity of lesions on MRI. Enhancement-pattern during the arterial-, portal- and late-phase on ultrasound, CT and MR study was assessed as well as the enhancement pattern during the hepatobiliary-phase on MRI.

Results: 23 patients were selected. The lesion was intraductal in 5 cases, periductal in 14 and intrahepatic in 4. 16 lesions were solid, 5 uniloculated cystic and 2 complex cystic. In five patients the lesion was simple cyst, with a signal intensity in T weighted (T1W) and T weighted (T2W) similar to the gallbladder. In two patients with complex cystic lesion, the solid component was heterogeneously hypointense in T W, hyperintense in T W with a restricted diffusion. The solid component showed heterogeneous contrast-enhancement on CT, MR and ultrasound. The tumour was intrahepatic in two patients, with signal hypointense in T W and hyperintense in T W. Diffusion was restricted. The lesions showed heterogeneous contrast-enhancement. The periductal lesions were hypointense in T W, hyperintense in T W with restricted diffusion. The lesion showed progressive contrast-enhancement. Peribiliary melanoma was hyperintense in T W, hyperintense in T W with restricted diffusion and progressively contrast-enhanced.

Conclusion: Biliary tumours can have a wide spectrum of radiologic appearances and consequently represent a diagnostic challenge for the radiologist. Advances in knowledge: MRI is the technique of choice in diagnosing biliary tumours, including rare (non-CCC) tumours.

Citing Articles

SIUMB recommendations on the use of ultrasound in neoplastic lesions of the gallbladder and extrahepatic biliary tract.

de Sio I, DOnofrio M, Mirk P, Bertolotto M, Priadko K, Schiavone C J Ultrasound. 2023; 26(3):725-731.

PMID: 37147558 PMC: 10469113. DOI: 10.1007/s40477-023-00788-2.


Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.

Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese M Biology (Basel). 2023; 12(2).

PMID: 36829492 PMC: 9952965. DOI: 10.3390/biology12020213.


A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

De Muzio F, Grassi F, DellAversana F, Fusco R, Danti G, Flammia F Diagnostics (Basel). 2022; 12(7).

PMID: 35885561 PMC: 9319674. DOI: 10.3390/diagnostics12071655.


A case of hepatic intraductal papillary neoplasm of the bile duct.

Mukaida E, Tamura A, Nishiya M, Katoh K, Sugai T, Yoshioka K BJR Case Rep. 2022; 8(1):20210172.

PMID: 35136649 PMC: 8803234. DOI: 10.1259/bjrcr.20210172.


Radiological assessment of secondary biliary tree lesions: an update.

Granata V, Fusco R, Setola S, Avallone A, Palaia R, Grassi R J Int Med Res. 2020; 48(6):300060519850398.

PMID: 32597280 PMC: 7432986. DOI: 10.1177/0300060519850398.


References
1.
Medina V, Darnell A, Bejarano N, Falco J, Musulen E, Martin J . Primary biliary tract malignant melanoma: US, CT, and MR findings. Abdom Imaging. 2004; 28(6):842-6. DOI: 10.1007/s00261-003-0051-9. View

2.
Granata V, Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R . Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Radiol Med. 2015; 121(2):122-31. DOI: 10.1007/s11547-015-0582-5. View

3.
Bartolotta T, Taibbi A, Midiri M, La Grutta L, De Maria M, Lagalla R . Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent. Radiol Med. 2010; 115(5):714-31. DOI: 10.1007/s11547-010-0506-3. View

4.
Kim K, Choi J, Park Y, Lee W, Kim B . Biliary cystadenoma of the liver. J Hepatobiliary Pancreat Surg. 1999; 5(3):348-52. DOI: 10.1007/s005340050058. View

5.
Granata V, Catalano O, Fusco R, Tatangelo F, Rega D, Nasti G . The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging. Abdom Imaging. 2015; 40(7):2364-71. DOI: 10.1007/s00261-015-0488-7. View